MassMutual Private Wealth & Trust’s Design Therapeutics DSGN Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio DSGN Stock Details DSGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.46K	Hold	239	–	–	﹤0.01%	1819
2026 Q1	$2.54K	Hold	239	–	–	﹤0.01%	1911
2025 Q4	$2.24K	Hold	239	–	–	﹤0.01%	1960
2025 Q3	$1.8K	Hold	239	–	–	﹤0.01%	2013
2025 Q2	$805	Hold	239	–	–	﹤0.01%	2159
2025 Q1	$923	Hold	239	–	–	﹤0.01%	2146
2024 Q4	$1.48K	Hold	239	–	–	﹤0.01%	1919
2024 Q3	$1.29K	Hold	239	–	–	﹤0.01%	1785
2024 Q2	$801	Hold	239	–	–	﹤0.01%	1868
2024 Q1	$963	Buy	+239	New	+$638	﹤0.01%	1713

Other funds holding DSGN

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

AlphaCentric Advisors San Juan, Puerto Rico $118M AUM

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

APW

Allied Private Wealth Boca Raton, Florida $156M AUM

MassMutual Private Wealth & Trust's DSGN Position: Q2 2026 in Review

MassMutual Private Wealth & Trust held its Design Therapeutics (DSGN) position steady in Q2 2026 at 239 shares worth $3.46K. The position accounts for ﹤0.01% of the portfolio, ranked #1819.

MassMutual Private Wealth & Trust first reported a position in DSGN in Q1 2024 and has held it in 10 quarters since. 21 funds tracked by Wall St. Rank hold DSGN as of Q2 2026.

MassMutual Private Wealth & Trust held 239 shares of Design Therapeutics worth $3.46K as of Q2 2026.
MassMutual Private Wealth & Trust left its Design Therapeutics share count unchanged in Q2 2026.
Design Therapeutics made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #1819 holding.
MassMutual Private Wealth & Trust first reported a position in Design Therapeutics in Q1 2024 and has held it in 10 quarters since.
21 funds tracked by Wall St. Rank held Design Therapeutics as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.